We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Comment & Response |

New Strategies to Treat High Cholesterol—Reply

William H. Shrank, MD, MSHS1; Jane Barlow, MD1
[+] Author Affiliations
1CVS Health, Woonsocket, Rhode Island
JAMA. 2016;315(11):1169-1170. doi:10.1001/jama.2015.18038.
Text Size: A A A
Published online


In Reply We share the goals of Drs Blum and Stone of optimizing appropriate, evidence-based, cost-effective therapy to prevent cardiovascular events and improve health. However, we disagree about the best way to establish guidelines to get there.

Blum and Stone state that the guidelines indicate that in high-risk patients, nonstatins could be added in “high-risk patients who have a less-than-anticipated response” to statin monotherapy. Yet the guidelines lack clarity in the definition of “less-than-anticipated” and call on prescribers to show appropriate restraint and caution when initiating the new, expensive PCSK-9 inhibitor class. Blum and Stone further note that the guidelines suggest that “clinicians preferentially prescribe drugs that have been shown in RCTs to provide ASCVD risk-reduction benefits that outweigh the potential for adverse effects,” but that those studies are still under way for the PCSK-9 inhibitors.


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview




March 15, 2016
Conrad B. Blum, MD; Neil J. Stone, MD
1Columbia University College of Physicians and Surgeons, New York, New York
2Feinberg School of Medicine, Northwestern University, Chicago, Illinois
JAMA. 2016;315(11):1169. doi:10.1001/jama.2015.18029.
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...